68
Participants
Start Date
May 30, 2018
Primary Completion Date
December 31, 2019
Study Completion Date
June 30, 2020
Pedra Tissue Perfusion Monitor
This study is a prospective single-centre, device observational study designed to enroll up to 60 evaluable subjects at 1 investigational site in the United Kingdom. Eligible subjects, who meet the requirements for one of the 3 distinct subject groups: (1) Critical Limb Ischaemia group, (2) Peripheral artery disease with superficial femoral arterial (SFA) or popliteal artery disease and (3) PAD-free group. Subjects who meet study eligibility criteria will be enrolled consecutively until the total number of subjects is enrolled per each group as outlined in the protocol. All subjects at the investigational site will be enrolled in the presence of a member of the Sponsor or selected designee in order to assist with the device operation and to verify that all protocol assessments are completed appropriately at baseline.
Addenbrooke's Hospital, Department of Vascular Surgery, Cambridge
Pedra Technology, PTE LTD
INDUSTRY